Matches 1 - 50 out of 403 1 2 3 4 5 6 7 8 9 >
Match Document Document Title
7608601 4′-Substituted nucleoside derivatives as inhibitors of HCV RNA replication  
The present invention relates to the use of nucleoside derivatives of formula I wherein B signifies a 9-purinyl residue B1 of formula or a 1-pyrimidyl residue B2 of formula...
7566781 Imidazopyridine compound  
The present invention provides an imidazopyridine compound represented by formula (I), wherein R 1 and R 2 each independently represent a C 1-6 alkyl group et al; R 3 and R 4 each...
7550501 Compounds and methods for treating toll-like receptor 2-related diseases and conditions  
The present invention relates to compounds and methods useful in the prevention or treatment of diseases or conditions associated with Toll-like receptor 2 activation.
7534809 Phospho-indoles as HIV inhibitors  
3-phosphoindole compounds for the treatment of retroviral infections, and particularly for HIV, are described. Also included are compositions comprising the 3-phosphoindole derivatives alone or in...
7528120 Aminopropanol derivatives  
Compounds of formula I: wherein R 1 , R 2 , n and m are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
7517867 Topoisomerase-targeting agents  
The invention provides compounds of formula I or formula II: wherein: the bond represented by — is a single bond or a double bond, and R 1 -R 5 , X, and Y have any of the meanings defined...
7517858 Prodrugs of pharmaceuticals with improved bioavailability  
Lipid prodrugs of pharmaceutical agents and their analogs that have increased anticancer, anti-viral, anti-inflammatory, anti-proliferative activity over the parent drug, and methods for making...
7494983 Ophthalmic compositions for treating ocular hypertension  
This invention relates to potent potassium channel blocker compounds of structural Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated...
7491710 Organophosphorus derivatives of indazoles and use thereof as medicinal products  
The present invention relates in particular to novel chemical compounds, particularly to novel organophosphorus derivatives of indazoles, to the compositions containing them, and to the use thereof...
7476661 Regulators of the hedgehog pathway, compositions and uses related thereto  
The present invention makes available, inter alia, methods and reagents for modulating smoothened-dependent pathway activation. In certain embodiments, the subject methods can be used to counteract...
7462609 Narcistatin prodrugs  
The present invention provides prodrugs derived from the sparingly soluble anticancer isocarbostyril narciclasine, a component of various Narcissus species, said prodrugs having potential for use...
7459444 Inhibitors of chymase  
The present invention is directed to a compound of formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof, and methods for treating inflammatory...
7410956 Caspase inhibitor prodrugs  
The present invention relates to compounds of formula I which are prodrugs of caspase inhibitors and pharmaceutically acceptable salts thereof. This invention further relates to the release of...
7407946 Quinazoline compounds  
Quinazoline derivatives of formula (I) wherein A is 5-membered heteroaryl containing a sulphur atom and optionally containing one or more nitrogen atoms; compositions containing them, processes for...
7365096 Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)  
Methods are disclosed for inhibiting or disrupting Janus tyrosine kinase 3 (Jak3) dependent function in cells of lymphoid or myeloid origin, especially for blocking proliferation and function of...
7365091 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX  
The present invention relates to derivatives of succinic and glutaric acids and analogues thereof, having the following general formula: useful as inhibitors of PHEX. These derivatives are...
7351698 Androgen receptor modulators and methods of use thereof  
Compounds of structural formula (I) as herein defined are disclosed as useful in a method for modulating the androgen receptor in a tissue selective manner in a patient in need of such modulation,...
7345082 Phosphinic acids  
The present invention relates to phosphinic acid derivatives of formula I wherein R 1 , R 2 , R 3 and R 4 are described hereinabove. These compounds can be used in the treatment or prevention...
7345032 Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl}phosphonic acid and esters thereof  
The present invention provides methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]et hyl}phosphonic acid, and esters thereof.
7300924 Anti-infective phosphonate analogs  
The invention is related to phosphorus substituted anti-infective compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as...
7282514 Reactive probes for two-photon fluorescent imaging and sensing  
Fluorescent dyes and probes are key components in multiphoton based fluorescence microscopy imaging of biological samples. In order to address the demand for better performing dyes for two-photon...
7253153 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof  
Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided where at least one of R 2 or R 3 is not hydrogen. The compounds of the present invention are...
7247610 Use of glutamate antagonists for the treatment of cancer  
Disclosed are methods for treating cancer by administering an inhibitor of the interaction of glutamate with the KA receptor complex.
7214701 Active substance combinations having insecticidal and acaricdal properties  
The invention relates to insecticidal mixtures for protecting plants against attack by pests comprising (a) compounds of the formula (I) in which W, X, Y, Z, A, B, D and G...
7176196 Bicyclic heterocycles as HIV integrase inhibitors  
The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds...
7138388 Methods to treat autoimmune and inflammatory conditions  
This invention provides methods for treating inflammatory or autoimmune diseases by contacting the affected cell or tissue with a therapeutic compound as described herein. Such pathologies include,...
7132427 Quinazolines and uses thereof  
This invention relates to compounds of the general formula: in which R A , R B , R C and R D are as defined herein, and to their preparation and use.
7129225 Protection against and treatment of hearing loss  
The present invention provides a method for protecting against or treating hearing loss in a subject. This method involves administering an effective amount of a protein tyrosine kinase inhibitor...
7098196 Regulators of the hedgehog pathway, compositions and uses related thereto  
The present invention makes available, inter alia, methods and reagents for modulating smoothened-dependent pathway activation. In certain embodiments, the subject methods can be used to counteract...
7041658 Method of inhibiting hair growth  
Disclosed herein are a method of inhibiting hair growth, which comprises administering an inhibitor of elastase-like enzymes or a neutral endopeptidase inhibitor, and use of an inhibitor of...
7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors  
The present invention is related to new substituted pyrrolidine derivatives of formula (I). Said compounds are preferably for use as pharmaceutically active compounds. Specifically, pyrrolidine...
6987100 Pharmaceutical compositions for treating bone lesions in multiple myeloma  
Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both...
6930101 Thiazolopyrimidines useful as TNFα inhibitors  
The invention provides derivatives of thiazolo[4,5-dl]pyrimidine and their use as inhibitors of proinflammatory cytokines.
6930100 Phosphate prodrugs of fluoroxindoles  
The present invention provides novel phosphate derivatives having the general Formula I wherein the wavy bond ( ) represents the racemate, the (R)-enantiomer or the (S)-enantiomer and A, B, R...
6908908 Biologically active 4H-benzo [1,4] oxazin-3-ones  
The invention is directed to 4h-benzo[1,4]oxazin-3-ones useful as peroxisome proliferator activated receptor gamma (PPARγ) agonists or antagonists. Pharmaceutical compositions comprising compounds...
6867200 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors  
The present invention provides novel compounds of the Formula (I): A-B, its prodrug forms, or pharmaceutically acceptable salts thereof, wherein A represents a saturated, unsaturated, or a...
6841559 Pyridinones to treat and prevent bacterial infections  
Novel pyridinones and their derivatives which are effective in treating or preventing Gram-negative bacterial infections are provided. The pyridinones are stable and easily derivatized; the methods...
6825211 Bicyclic metabotropic glutamate receptor ligands  
The present invention provides bicyclic metabotropic glutamate receptor ligands, as well as compositions comprising such ligands, and methods for their use.
6794371 Aminoalkylenephosphonates for treatment of bone disorders  
A method for preventing loss of bone mineral in mammals which method comprises administering to a mammal an amount of an aminoalkylenephosphonate which is effective to prevent or minimize loss of...
6777445 Fullerene pharmaceutical compositions for preventing or treating disorders  
The present invention relates to a method for treating a disease, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a fullerene. The diseases...
6727233 Medicinal compositions for treating osseous lesion in multiple myeloma  
Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both...
6706698 α-Substituted β-aminoethyl phosphonate derivatives  
The present invention relates to novel α-substituted-β-aminoethylphosphonate and α-substituted-β-aminovinylphosphonate derivatives and their uses for lowering plasma levels of apo (a), Lp(a),...
6699855 Inhibitors of hepatitis C virus NS3 protease  
The present invention relates to compounds of Formula (I): wherein A 1 is methylene, ethylene or propylene group and A 2 is N or CR 5 , or stereoisomeric forms, stereoisomeric mixtures, or...
6673780 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses  
The present invention relates to novel sulfoxide and bis-sulfoxide compounds, compositions comprising sulfoxide and bis-sulfoxide compounds, and methods useful for treating and preventing...
6645950 Benzimidazole vascular damaging agents  
Vascular damaging agents composed of substituted 5(6)-substituted benzimidazole-2-carbamates are provided. These agents are useful in the preparation of medicaments for the treatment of diseases...
6638960 Halogenobenzimidazoles and their use as microbicides  
New halogenobenzimidazoles of the formula in which A, R 1 , R 2 , R 3 , R 4 and X have the meanings given in the description, and their acid addition salts and metal salt complexes, a process...
6635626 Imidazoquinoxaline protein tyrosine kinase inhibitors  
Novel imidazoquinoxalines and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated...
6596709 6-sulphanoyl-3-quinolylphosphonic acid compounds  
The invention relates to a compound of formula (I): wherein: X represents chlorine or fluorine or CF 3 , R represents hydrogen or a group and methods for using the same.
6555536 Biologically active 4H-benzo &lsqb 1,4&rsqb oxazin-3-ones  
The invention is directed to 4h-benzo[1,4]oxazin-3-ones useful as peroxisome proliferator activated receptor gamma (PPARγ) agonists or antagonists. Pharmaceutical compositions comprising compounds...
6555528 Derivatized biotin compounds and methods of use  
An efficient synthesis for the selective and efficient 1′-N derivatization of biotin is reported. The derivatized biotin acts as a stable analog of the carboxyphosphate intermediate in...
Matches 1 - 50 out of 403 1 2 3 4 5 6 7 8 9 >